HomeTagsKEYTRUDA

KEYTRUDA

Healthcare

Merck’s KEYTRUDA Plus Chemotherapy Significantly Improved Overall Survival Compared to Chemotherapy Alone in Patients With Advanced or Unresectable Biliary Tract Cancer

Business Wire - April 17, 2023

Merck, known as MSD outside of the United States and Canada, announced results from the Phase 3 KEYNOTE-966 trial investigating KEYTRUDA, Merck’s anti-PD-1 therapy,...

Biotechnology

Roche Receives FDA Approval for VENTANA MMR RxDx Panel

PR Newswire - August 11, 2022

Roche announced US Food and Drug Administration (FDA) approval of a label expansion for the VENTANA MMR RxDx Panel. This approval advances the company's...